Hepatitis B Topics HBV Prevention
U.S. Approves New Hepatitis B Vaccine as Public Health Agencies Update Guidelines
- Details
- Category: HBV Vaccines
- Published on Thursday, 30 November 2017 00:00
- Written by Liz Highleyman
On November 9 the U.S. Food and Drug Administration(FDA) approved Heplisav-B, a new vaccine that provides protection against all known subtypes of hepatitis B virus (HBV) with 2 rather than 3 doses, which is expected to reduce the number of people who do not complete the vaccine series.
PAS 2017: Children on Immunosuppressive Therapy May Lose Hepatitis B Vaccine Protection
- Details
- Category: HBV Vaccines
- Published on Tuesday, 16 May 2017 00:00
- Written by Liz Highleyman
More than half of children treated with immunosuppressive drugs for gastrointestinal or rheumatological conditions no longer had protective levels of antibodies against hepatitis B virus (HBV) and may require repeat vaccinations, according to a study presented at the Pediatric Academic Societies Meeting last week in San Francisco.
HIV Controllers Respond Better to Hepatitis B Vaccine
- Details
- Category: HBV Vaccines
- Published on Tuesday, 16 September 2014 00:00
- Written by Liz Highleyman
HIV positive natural controllers who maintain undetectable or low viral load without antiretroviral therapy (ART) are more likely to achieve adequate response to hepatitis B virus (HBV) vaccination and have improved survival, according to a study published in the August 21 edition of the open-access journal PLoS ONE.
Telbivudine Prevents Mother-to-Child Hepatitis B Virus Transmission
- Details
- Category: HBV Prevention
- Published on Wednesday, 17 June 2015 00:00
- Written by Liz Highleyman
Women with a high hepatitis B viral load who were treated with the antiviral drug telbivudine (Tyzeka) had a lower risk of transmitting the virus to their babies during pregnancy or birth -- in fact, none did so -- compared to untreated women whose infants only received standard immunoprophylaxis, according to a Chinese study reported in the June edition of Clinical Gastroenterology and Hepatology.
EASL 2014: Sci-B-Vac Bests Engerix-B for Preventing Mother-to-Child HBV Transmission
- Details
- Category: HBV Vaccines
- Published on Tuesday, 29 April 2014 00:00
- Written by Liz Highleyman
An investigational vaccine known as Sci-B-Vac given to babies born to women with hepatitis B was more effective at preventing HBV infection than the widely used Engerix-B vaccine, according to a report at the EASL International Liver Congress this month in London.
EASL 2015: Expanded Vaccination and Treatment Could Help Eliminate Hepatitis B Worldwide
- Details
- Category: HBV Treatment
- Published on Friday, 24 April 2015 00:00
- Written by Liz Highleyman
While universal infant hepatitis B virus (HBV) vaccination has already led to major advances in reducing new infections in some settings, further expansion of prevention and treatment are needed to significantly reduce HBV transmission and liver disease mortality, according to an analysis presented at the European Association for the Study of the Liver (EASL) 50th International Liver Congress this week in Vienna.
CDC Updates Guidance for Hepatitis B Vaccination of Health-care Providers
- Details
- Category: HBV Vaccines
- Published on Thursday, 16 January 2014 00:00
- Written by Liz Highleyman
The U.S. Centers for Disease Control and Prevention (CDC) has published updated guidance for evaluating and ensuring protection against hepatitis B virus (HBV) for health-care workers, as well as post-exposure prophylaxis recommendations for those without adequate vaccine protection.
More Articles...
- AASLD 2013: Hepatitis B Vaccine Protection Lasts at Least 30 Years
- IDWeek 2013: Tenofovir May Help Prevent Mother-to-child Hepatitis B Transmission
- FDA Rejects Heplisav Hepatitis B Vaccine Seeking More Safety Data
- HIV+ Less Likely to Respond to Hepatitis B Vaccine, but More Shots Increase Protection
- Teens Vaccinated Against Hepatitis B as Infants May Lose Immunity
Web Design and Development by